The authors of the paper – Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian Kowol, Bernhard Keppler and Walter Berger – examined the published results relating to the interaction between the immune system and metal chemotherapy drugs, and could show that, rather than damaging the immune system through their cytotoxic effect, as has been generally assumed, metal-based anti tumor drugs can even boost the immune response against cancer.
"Chemical Reviews" with an impact factor of 52,613 is the leading chemical research journal and fourth among scientific journals worldwide.
- Metal Drugs and the Anticancer Immune Response
Bernhard Englinger, Christine Pirker, Petra Heffeter, Alessio Terenzi, Christian R. Kowol, Bernhard K. Keppler, and Walter Berger
Chemical Reviews Article ASAP
DOI: 10.1021/acs.chemrev.8b00396 - Metallhaltige Chemotherapien verstärken Wirkung der Immuntherapie bei Krebs
Metal chemotherapy drugs boost the impact of immunotherapy in cancer
(Press Release 18.12.2018, University of Vienna) - Metallhaltige Chemotherapien verstärken Wirkung der Immuntherapie bei Krebs
Metal chemotherapy drugs boost the impact of immunotherapy in cancer
(Press Release 18.12.2018, Medical University of Vienna) - Metallhaltige Chemo macht Krebs-Immuntherapien wirksamer (Der Standard, 18.12.2018)
